BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34496060)

  • 1. Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study.
    Schiepatti A; Rej A; Maimaris S; Cross SS; Porta P; Aziz I; Key T; Goodwin J; Therrien A; Yoosuf S; Leffler DA; Silvester JA; Klersy C; Biagi F; Sanders DS
    Aliment Pharmacol Ther; 2021 Nov; 54(10):1278-1289. PubMed ID: 34496060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue.
    Cataldo F; Lio D; Marino V; Picarelli A; Ventura A; Corazza GR
    Gut; 2000 Sep; 47(3):366-9. PubMed ID: 10940273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
    Ciacci C; Bai JC; Holmes G; Al-Toma A; Biagi F; Carroccio A; Ciccocioppo R; Di Sabatino A; Gingold-Belfer R; Jinga M; Makharia G; Niveloni S; Norman GL; Rostami K; Sanders DS; Smecuol E; Villanacci V; Vivas S; Zingone F;
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1005-1014. PubMed ID: 37696284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deamidated gliadin peptide and tissue transglutaminase antibodies in children with coeliac disease: A correlation study.
    Saadah OI; Alamri AM; Al-Mughales JA
    Arab J Gastroenterol; 2020 Sep; 21(3):174-178. PubMed ID: 32732170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and flow cytometry analysis of seronegative celiac disease: a cohort study.
    Ríos León R; Crespo Pérez L; Rodríguez de Santiago E; Roy Ariño G; De Andrés Martín A; García Hoz Jiménez C; Sánchez Rodríguez E; Saiz González A; León Prieto F; Albillos A
    Scand J Gastroenterol; 2019 May; 54(5):563-570. PubMed ID: 31057009
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated positive deamidated gliadin peptide-IgG has limited diagnostic utility in coeliac disease.
    Vootukuru N; Singh H; Giles E
    J Paediatr Child Health; 2022 Sep; 58(9):1648-1652. PubMed ID: 35726522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of deamidated gliadin peptide antibodies in diagnosing coeliac disease in children younger than 3 years old.
    Hill M; Watkins R; Leonard-Puppa E; Waddell J; Blanchard S; Kader H
    J Paediatr Child Health; 2022 May; 58(5):815-819. PubMed ID: 34866267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
    Arigliani M; Rech Morassutti F; Fabris M; Melli P; Tonutti E; Cogo P
    Ital J Pediatr; 2017 Aug; 43(1):70. PubMed ID: 28797308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will the Real Coeliac Disease Please Stand Up? Coeliac Disease Prevalence in the German LIFE Child Study.
    Händel N; Mothes T; Petroff D; Baber R; Jurkutat A; Flemming G; Kiess W; Hiemisch A; Körner A; Schlumberger W; Thiery J; Wolf J
    J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):494-500. PubMed ID: 29901554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coeliac disease.
    Glissen Brown JR; Singh P
    Paediatr Int Child Health; 2019 Feb; 39(1):23-31. PubMed ID: 30099930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.
    Korponay-Szabó IR; Dahlbom I; Laurila K; Koskinen S; Woolley N; Partanen J; Kovács JB; Mäki M; Hansson T
    Gut; 2003 Nov; 52(11):1567-71. PubMed ID: 14570724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New serology assays can detect gluten sensitivity among enteropathy patients seronegative for anti-tissue transglutaminase.
    Sugai E; Hwang HJ; Vázquez H; Smecuol E; Niveloni S; Mazure R; Mauriño E; Aeschlimann P; Binder W; Aeschlimann D; Bai JC
    Clin Chem; 2010 Apr; 56(4):661-5. PubMed ID: 20022983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.
    Ortiz G; Messere G; Toca MDC; Fiorucci M; Bigliardi R; Vidal J; Reynoso R
    Arch Argent Pediatr; 2019 Feb; 117(1):52-55. PubMed ID: 30652447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
    Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
    Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
    Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
    Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive prediction of persistent villous atrophy in celiac disease.
    Packova B; Kovalcikova P; Pavlovsky Z; Bartusek D; Prokesova J; Dolina J; Kroupa R
    World J Gastroenterol; 2020 Jul; 26(26):3780-3791. PubMed ID: 32774057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.